Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 36

1.

Incidence and distribution of UroSEEK gene panel in a multi-institutional cohort of bladder urothelial carcinoma.

Eich ML, Rodriguez Pena MDC, Springer SU, Taheri D, Tregnago AC, Salles DC, Bezerra SM, Cunha IW, Fujita K, Ertoy D, Bivalacqua TJ, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ.

Mod Pathol. 2019 Oct;32(10):1544-1550. doi: 10.1038/s41379-019-0276-y. Epub 2019 Apr 25.

2.

Targeted sequencing of plasmacytoid urothelial carcinoma reveals frequent TERT promoter mutations.

Palsgrove DN, Taheri D, Springer SU, Cowan M, Guner G, Mendoza Rodriguez MA, Rodriguez Pena MDC, Wang Y, Kinde I, Ricardo BFP, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ.

Hum Pathol. 2019 Mar;85:1-9. doi: 10.1016/j.humpath.2018.10.033. Epub 2018 Nov 14.

PMID:
30447301
3.

Correction: Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ.

Elife. 2018 Nov 12;7. pii: e43237. doi: 10.7554/eLife.43237.

4.

Successful Treatment of Posttransplant Recurrent Complement C3 Glomerulopathy with Eculizumab.

Sahin H, Gok Oguz E, Akoglu H, Atilgan G, Ulusal Okyay G, Karaveli Gursoy G, Kip Teymur T, Ertoy D, Canbakan B, Ayli MD.

Iran J Kidney Dis. 2018 Oct;12(5):315-318.

5.

Non-invasive detection of urothelial cancer through the analysis of driver gene mutations and aneuploidy.

Springer SU, Chen CH, Rodriguez Pena MDC, Li L, Douville C, Wang Y, Cohen JD, Taheri D, Silliman N, Schaefer J, Ptak J, Dobbyn L, Papoli M, Kinde I, Afsari B, Tregnago AC, Bezerra SM, VandenBussche C, Fujita K, Ertoy D, Cunha IW, Yu L, Bivalacqua TJ, Grollman AP, Diaz LA, Karchin R, Danilova L, Huang CY, Shun CT, Turesky RJ, Yun BH, Rosenquist TA, Pu YS, Hruban RH, Tomasetti C, Papadopoulos N, Kinzler KW, Vogelstein B, Dickman KG, Netto GJ.

Elife. 2018 Mar 20;7. pii: e32143. doi: 10.7554/eLife.32143. Erratum in: Elife. 2018 Nov 12;7:.

6.

Spectrum of genetic mutations in de novo PUNLMP of the urinary bladder.

Rodriguez Pena MDC, Tregnago AC, Eich ML, Springer S, Wang Y, Taheri D, Ertoy D, Fujita K, Bezerra SM, Cunha IW, Raspollini MR, Yu L, Bivalacqua TJ, Papadopoulos N, Kinzler KW, Vogelstein B, Netto GJ.

Virchows Arch. 2017 Dec;471(6):761-767. doi: 10.1007/s00428-017-2164-5. Epub 2017 Jun 8.

PMID:
28597078
7.

High prevalence of TERT promoter mutations in micropapillary urothelial carcinoma.

Nguyen D, Taheri D, Springer S, Cowan M, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Ricardo BF, Cunha I, Fujita K, Ertoy D, Kinzler KW, Bivalacqua TJ, Papadopoulos N, Vogelstein B, Netto GJ.

Virchows Arch. 2016 Oct;469(4):427-34. doi: 10.1007/s00428-016-2001-2. Epub 2016 Aug 12.

8.

Detection of TERT promoter mutations in primary adenocarcinoma of the urinary bladder.

Cowan ML, Springer S, Nguyen D, Taheri D, Guner G, Mendoza Rodriguez MA, Wang Y, Kinde I, Del Carmen Rodriguez Pena M, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Kinzler K, Bivalacqua T, Papadopoulos N, Vogelstein B, Netto GJ.

Hum Pathol. 2016 Jul;53:8-13. doi: 10.1016/j.humpath.2016.02.009. Epub 2016 Mar 10.

9.

High prevalence of TERT promoter mutations in primary squamous cell carcinoma of the urinary bladder.

Cowan M, Springer S, Nguyen D, Taheri D, Guner G, Rodriguez MA, Wang Y, Kinde I, VandenBussche CJ, Olson MT, Cunha I, Fujita K, Ertoy D, Bivalacqua TJ, Kinzler K, Vogelstein B, Netto GJ, Papadopoulos N.

Mod Pathol. 2016 May;29(5):511-5. doi: 10.1038/modpathol.2016.53. Epub 2016 Mar 11.

10.

The role of GATA binding protein 3 in the differential diagnosis of collecting duct and upper tract urothelial carcinomas.

Gonzalez-Roibon N, Albadine R, Sharma R, Faraj SF, Illei PB, Argani P, Ertoy D, Allaf ME, Netto GJ.

Hum Pathol. 2013 Dec;44(12):2651-7. doi: 10.1016/j.humpath.2013.07.006. Epub 2013 Sep 24.

PMID:
24071011
11.

PAX8 (+)/p63 (-) immunostaining pattern in renal collecting duct carcinoma (CDC): a useful immunoprofile in the differential diagnosis of CDC versus urothelial carcinoma of upper urinary tract.

Albadine R, Schultz L, Illei P, Ertoy D, Hicks J, Sharma R, Epstein JI, Netto GJ.

Am J Surg Pathol. 2010 Jul;34(7):965-9. doi: 10.1097/PAS.0b013e3181dc5e8a.

12.

Renal cell carcinoma with inferior vena cava thrombus: the Hacettepe experience.

Yazici S, Inci K, Bilen CY, Gudeloglu A, Akdogan B, Ertoy D, Kaynaroglu V, Demircin M, Ozen H.

Urol Oncol. 2010 Nov-Dec;28(6):603-9. doi: 10.1016/j.urolonc.2008.11.017. Epub 2009 Jan 26.

PMID:
19171489
13.

Testicular teratoma and anti-N-methyl-D-aspartate receptor-associated encephalitis.

Eker A, Saka E, Dalmau J, Kurne A, Bilen C, Ozen H, Ertoy D, Oguz KK, Elibol B.

J Neurol Neurosurg Psychiatry. 2008 Sep;79(9):1082-3. doi: 10.1136/jnnp.2008.147611. No abstract available.

PMID:
18708569
14.

Effects of amifostine on glycerol-pretreated rabbit kidneys.

Barun S, Ertoy D, Dileköz E, Müftüoglu S, Erten Y, Sucak G, Bali M, Tekeli N, Sarioglu Y, Ercan ZS.

Basic Clin Pharmacol Toxicol. 2005 Sep;97(3):168-73.

15.

Membranoproliferative glomerulonephritis associated with type 1 diabetes mellitus and Hashimoto's thyroiditis.

Dizdar O, Kahraman S, Gençtoy G, Ertoy D, Arici M, Altun B, Yasavul U, Turgan C.

Nephrol Dial Transplant. 2004 Apr;19(4):988-9. No abstract available.

PMID:
15031362
16.

Preventive effect of pentoxifylline on renal scarring in rat model of pyelonephritis.

Yagmurlu A, Boleken ME, Ertoy D, Ozsan M, Gokcora IH, Dindar H.

Urology. 2003 May;61(5):1037-41.

PMID:
12736043
17.

Giant eccrine acrospiroma: A case report and review of the literature.

Koçer U, Aksoy HM, Tiftikcioðlu YÖ, Ertoy D, Karaaslan O.

Can J Plast Surg. 2003 Spring;11(1):43-6.

18.

Effects of growth factors on doxorubicin-induced skin necrosis: documentation of histomorphological alterations and early treatment by GM-CSF and G-CSF.

Vargel I, Erdem A, Ertoy D, Pinar A, Erk Y, Altundag MK, Gullu I.

Ann Plast Surg. 2002 Dec;49(6):646-53.

PMID:
12461449
19.

Protective effect of roscovitine on renal ischemia-reperfusion injury.

Aydemir A, Abbasoglu O, Topaloglu S, Ertoy D, Ayhan A, Kilinç K, Karabulut E, Sayek I.

Transplant Proc. 2002 Sep;34(6):2027-8. No abstract available.

PMID:
12270300
20.

Insights derived from ACE knockout mice.

Cole J, Ertoy D, Bernstein KE.

J Renin Angiotensin Aldosterone Syst. 2000 Jun;1(2):137-41. Review.

PMID:
11967804

Supplemental Content

Loading ...
Support Center